Newsroom | 60688 results

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (Nasdaq : HYFT), une société d'IA bio-native axée sur la découverte de produits biologiques et le développement de médicaments optimisé par l'IA, annonce aujourd'hui ses résultats financiers pour le troisième trimestre de l'exercice 2026, clos le 31 janvier 2026. MindWalk tiendra sa téléconférence sur les résultats du troisième trimestre de l'exercice 2026 aujourd'hui à 10h30, heure de l'Est. Le chiffre d'affaires du T3 s'établit à 4,2 mil...

MINNEAPOLIS--(BUSINESS WIRE)--Pivot Bio, one of the world's leading innovative agtech companies, will be taking the stage at the World Agri-Tech Innovation Summit taking place March 16–18, 2026. Chris Abbott, chief executive officer, will participate in a fireside chat titled “Capturing Innovation in a Transformed Agri-Food Landscape” on the Main Stage on March 17 at 4:15 p.m. PT. Abbott will be joined by Scott H. Hutchins, Under Secretary for Research, Education, and Economics & Chief Scie...

PHILADELPHIA--(BUSINESS WIRE)--GSK’s RSV vaccine, AREXVY, approved in US for expanded age indication in adults aged 18–49 years at increased risk...

BERKELEY, Calif.--(BUSINESS WIRE)--We are enabling validation and rapid iteration so researchers can turn cofolding models into scientific infrastructure that speeds drug discovery...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC (“Ignite”), a commercial-stage precision oncology company focused on addressing a critical challenge in cancer care: optimizing therapy selection. Ignite’s functional proteomics platform has demonstrated the ability to identify cancer therapy responses that may not be cap...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. The presentation will be accessible via a live webcast on the Events and Presentations page in the Investo...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies reports financial results for FY 2025, including record revenue and unit sales for the CyPath Lung test for lung cancer....

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc., a clinical-stage pharmaceutical company developing innovative therapies for diabetes based on the breakthrough discovery of the role of TXNIP in disease progression, today announced the expansion of a program-related investment (PRI) made by The Leona M. and Harry B. Helmsley Charitable Trust in furtherance of their charitable purpose. The expanded PRI, in the form of a loan, provides TIXiMED with an additional $2.2 million to support the compan...

東京--(BUSINESS WIRE)--(美國商業資訊)-- Telexistence (TX)今日宣布，其已入選第第二期實體AI加速計畫(Physical AI Fellowship)。該虛擬計畫由Amazon Web Services (AWS) Startups和NVIDIA Inception共同創設，旨在協助高潛力機器人新創公司建構、完善和擴充實體AI解決方案。繼2025年秋季首期計畫後，2026年計畫匯聚了九家前景廣闊的實體AI新創企業，涵蓋農業、建築和再生能源、工業自動化、零售和物流以及人形機器人應用等領域。 在全球入選的九家企業中，TX是第一家也是唯一一家獲選的日本企業。 透過實體AI加速計畫，TX將獲得一對一技術指導、運算資源和市場推廣機會。這些支援將協助TX加快研發穩定可靠、可實際應用的產品。包括TX在內的入選企業還將獲得AWS生成式AI創新中心(GenAIIC)科學家和專家的支援、AWS額度和NVIDIA資源，以及使用MassRobotics設施及其更廣泛機器人社群網路的許可權。 此次機會將協助TX開發和部署與真實世界機器人系統相整合的機器人基礎模型。藉助AWS...